Tumor Antigens and Their Role in Immune Response in Melanoma

tumor antigen s with immunopeptidomics - Nature  Biotechnology"/>Strategies for the Identification of T Cell–Recognized Tumor Antigens in  Hematological Malignancies for Improved Graft-versus-Tumor Responses after  Allogeneic Blood and Marrow Transplantation - ScienceDirect

The Of PeptiCHIP: A Microfluidic Platform for Tumor Antigen

For basic info, Learn more about Scientific Studies. Layout table for eligibility details Ages Eligible for Study: 18 Years to 80 Years (Adult, Older Grownup )Sexes Eligible for Research Study: All Accepts Healthy Volunteers: No Inclusion Criteria: Strong sophisticated deadly growths Age between18 and 80 years Life span is greater than three months Exclusion Criteria: Benign tumor Life span is less than 3 months Serious medical comorbidity Others Go to To find out more about this research study, you or your doctor may get in touch with the research study research study staff using the contact information provided by the sponsor. gov identifier( NCT number ): Design table for area details The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China, 510260 Contact: Zhenfeng Zhang, MD, Ph, D +862039195966 zhangzhf@gzhmu. edu.cn Contact: Bingjia He, MD +862039195965 464677938@qq. com Second Affiliated Hospital of Guangzhou Medical University Guangdong Zhaotai In

, Vivo Biomedicine Co. Design table for private investigator info Principal Investigator: Zhenfeng Zhang, MD, Ph, D 2nd Affiliated Hospital of Guangzhou Medical University Go to Design table for additonal information Responsible Party: Second Affiliated Hospital of Guangzhou Medical University Clinical, Trials. gov Identifier: Other Study ID Numbers: Cp, G-ODN on tumors First Posted: July 7, 2021 Key Record Dates Last Update Posted: July 7, 2021 Last Verified: June 2021 Individual Individual Data( IPD )Sharing Statement: Strategy to Share IPD: No Design table for extra info Studies a U.S. FDA-regulated Gadget Product: No Additional relevant Me, SH terms: Layout table for Me, SH terms Cancer, Hepatocellular, Neoplasms, Adenocarcinoma, Cancer, Neoplasms, Glandular and Epithelial, Neoplasms by Histologic Type, Liver Neoplasms, Digestion System Neoplasms Neoplasms by Website, Gastrointestinal System Illness, Liver Illness, CPG-oligonucleotide, Adjuvants, Immunologic, Immunologic Aspects, Physiological Effects of Drugs. For this factor, they are always utilized along with other tests. In breast cancer care, 3 tumor markers-- cancer antigen 15-3( CA 15-3), cancer antigen 27. 29( CA 27. 29 ), and carcinoembryonic antigen( CEA)-- have actually been utilized to assist keep track of metastatic breast cancer( innovative illness), however they have actually not been discovered to be useful to find a breast cancer reoccurrence or extend lives in patients who had early-stage breast cancer and who are now disease-free.